menu search

Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference

Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
AUSTIN, Texas, April 26, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that Remi Barbier, President & Chief Executive Officer, has been invited to present at the 2023 H.C. Wainwright BioConnect Investor Conference in New York. In addition, management will be available for one-on-one […] The post Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference appeared first on Forex... Read More
Posted: Apr 26 2023, 13:12
Author Name: forextv
Views: 102241

Search within

Pages Search Results: